GLP-1s are not going anywhere pharma manufacturers continue to evolve their GLP-1/GIP product offerings (e.g., Eli Lillys Zepbound is the newest on the market), and the number of addressable indications is increasing (e.g., recent clinical evidence that may merit further FDA approval of GLP-1s for cardio-metabolic, nephrological and neurological indications)
You can call us at (412) 802-6100 or contact us online anytime
A novel discussion topic has been the link between polycystic ovarian syndrome and the absorption of vitamins and minerals
Analytical Validation, Formulation, and Storage Research grade AOD9604 is supplied as a lyophilized white powder in glass vials at 99% purity, verified by HPLC with a batchspecific certificate of analysis included
Focus on easily digestible sources: fish, eggs, and slow-cooked meats
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension